Cargando…
Local Immune Responsiveness of Mice Bearing Premalignant Oral Lesions to PD-1 Antibody Treatment
A carcinogen-induced premalignant oral lesion model that progresses to oral cancer was used to examine the immunological impact of a 5-week treatment regimen to block programmed cell death protein 1 (PD-1). PD-1 antibody treatment resulted in concurrent, but transient, increases in interleukin (IL)-...
Autores principales: | Levingston, Corinne A., Young, M. Rita I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483881/ https://www.ncbi.nlm.nih.gov/pubmed/28574425 http://dx.doi.org/10.3390/cancers9060062 |
Ejemplares similares
-
Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD‐1 antibodies
por: Levingston, Corinne A., et al.
Publicado: (2017) -
Cytokine and Adipokine Levels in Patients with Premalignant Oral Lesions or in Patients with Oral Cancer Who Did or Did Not Receive 1α,25-Dihydroxyvitamin D(3) Treatment upon Cancer Diagnosis
por: Young, M. Rita I., et al.
Publicado: (2015) -
Indomethacin Treatment of Mice with Premalignant Oral Lesions Sustains Cytokine Production and Slows Progression to Cancer
por: Johnson, Sara D., et al.
Publicado: (2016) -
Role of IL-23 signaling in the progression of premalignant oral lesions to cancer
por: Caughron, Blaine, et al.
Publicado: (2018) -
Local Anti–PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model
por: Shi, Yewen, et al.
Publicado: (2021)